BML, Inc. (BMLKF)
OTCMKTS · Delayed Price · Currency is USD
24.10
-0.86 (-3.45%)
At close: Jan 8, 2026
BML, Inc. Revenue
BML, Inc. had revenue of 38.85B JPY in the quarter ending December 31, 2025, with 4.41% growth. This brings the company's revenue in the last twelve months to 149.09B, up 5.49% year-over-year. In the fiscal year ending March 31, 2025, BML, Inc. had annual revenue of 143.19B with 3.79% growth.
Revenue (ttm)
149.09B JPY
Revenue Growth
+5.49%
P/S Ratio
1.03
Revenue / Employee
32.71M JPY
Employees
4,558
Market Cap
983.24M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 143.19B | 5.23B | 3.79% |
| Mar 31, 2024 | 137.96B | -21.50B | -13.48% |
| Mar 31, 2023 | 159.46B | -26.61B | -14.30% |
| Mar 31, 2022 | 186.07B | 47.50B | 34.28% |
| Mar 31, 2021 | 138.57B | 17.84B | 14.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global Cord Blood | 196.10M |
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Interpace Biosciences | 41.92M |
| Psychemedics | 19.69M |
| China New Energy Group Company | 12.51M |
| Aspira Women's Health | 9.34M |
| Longduoduo Company | 4.15M |